Metabolism of TC-81, a New Dihydropyridine Calcium Entry Blocker, in Rats and Dogs.

Drug Metabolism and Pharmacokinetics
doi 10.2133/dmpk.7.853
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society for the Study of Xenobiotics

Related search

A Different Dihydropyridine Calcium Channel Blocker in Hypertensive Patients Who Developed Pedal Edema on Dihydropyridine Calcium Channel Blocker Therapy

Cumhuriyet Medical Journal
Medicine
2014English

Effects of a Calcium-Entry Blocker (Diltiazem) on Regional Myocardial Flow and Function During Exercise in Conscious Dogs

Circulation
Cardiovascular MedicinePhysiologyCardiology
1984English

Cloudy Peritoneal Fluid Attributable to Non-Dihydropyridine Calcium Channel Blocker

Peritoneal Dialysis International
MedicineNephrology
2012English

Nilvadipine, a New Calcium Channel Blocker, Reduces Ischemic Brain Injury in Rats.

The Japanese Journal of Pharmacology
1991English

Metabolism of a New 1,4-Dihydropyridine Calcium Antagonist, Pranidipine, by cDNA-expressed Human Cytochrome P450.

Drug Metabolism and Pharmacokinetics
1998English

Hypoglycaemic Brain Damage: Effect of a Dihydropyridine Calcium Channel Antagonist in Rats

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1996English

Review of TC-2019-81

2019English

Structural Studies of a New Dihydropyridine Calcium Channel Antagonist, Nilvadipine.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1986English

Review of TC-2019-81

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy